Fabrication of pea protein-tannic acid complexes: Impact on formation, stability, and digestion of flaxseed oil emulsions.

There is growing interest in the identification of plant-based functional ingredients for utilization within the food industry. Complexes were fabricated from pea protein (PP) and tannic acid (TA) and then their ability to act as antioxidant emulsifiers in flaxseed oil-in-water emulsions was studied. PP-TA complex formation was investigated using isothermal titration calorimetry and turbidity analysis, which suggested hydrogen bonding and hydrophobic interactions were important in their assembly. PP-TA-stabilized emulsions containing small droplets could be formed at relatively high TA levels. Moreover, PP-TA complexes had strong antioxidant activity, which extended the shelf life of flaxseed oil emulsions. The composition of the PP-TA complexes impacted the aggregation state of the lipid droplets under simulated gastric conditions, which affected the rate and extent of lipid digestion. This study shows PP-TA complexes can be used for fabricating flaxseed oil delivery systems with enhanced oxidative stability and good digestibility.

Encapsulation of flaxseed oil using a benchtop spray dryer for legume protein-maltodextrin microcapsule preparation.

Flaxseed oil was microencapsulated employing a wall material matrix of either chickpea (CPI) or lentil protein isolate (LPI) and maltodextrin using a benchtop spray dryer. Effects of emulsion formulation (oil, protein and maltodextrin levels) and protein source (CPI vs LPI) on the physicochemical characteristics, oxidative stability, and release properties of the resulting capsules were investigated. Microcapsule formulations containing higher oil levels (20% oil, 20% protein, 60% maltodextrin) were found to have higher surface oil and lower encapsulation efficiencies. Overall, LPI-maltodextrin capsules gave higher flaxseed oil encapsulation efficiencies (∼88.0%) relative to CPI-maltodextrin matrices (∼86.3%). However, both designs were found to provide encapsulated flaxseed oil protection against oxidation over a 25 d room temperature storage study relative to free oil. Overall, ∼37.6% of encapsulated flaxseed oil was released after 2 h under simulated gastric fluid, followed by the release of an additional ∼46.6% over a 3 h period under simulated intestinal fluid conditions.

Transfer rate of α-linolenic acid from abomasally infused flaxseed oil into milk fat and the effects on milk fatty acid composition in dairy cows.

The objectives of the present study were to evaluate the transfer efficiency of α-linolenic acid (ALA) from the abomasum into milk fat, its interaction with milk fat content and yield, and the relationship between ALA and C16:0 in milk fat. Three rumen-fistulated multiparous Holstein cows at midlactation were used in a 3×3 Latin square design. Treatments consisted of abomasal infusion of (1) 110 mL of water/d (control), (2) 110 mL of flaxseed oil/d (low flaxseed oil, LFO), and (3) 220 mL of flaxseed oil/d (high flaxseed oil, HFO). Experimental periods were continued for 2 wk and fat supplements were infused abomasally during the last 7 d of each period. Average dry matter intake and milk yield were not affected by oil infusion. Milk fat and lactose content tended to be greater with flaxseed infusion compared with the control. Plasma ALA was 2.9- and 4.0-fold greater with LFO and HFO, respectively. The apparent transfer efficiency of ALA to milk was 44.8 and 45.7% with LFO and HFO, respectively. The C16:0 content in milk fat was decreased by 3.59 and 5.25 percentage units, whereas the ALA content was increased by 1.68 and 3.09 percentage units with LFO and HFO, respectively. Similarly, C18:2n-6 was increased by 0.95 and 1.31 percentage units with LFA and HFO, respectively, without changes in other fatty acids (FA). Total polyunsaturated FA was 4.4 and 2.7% lower in the HFO and LFO, respectively, than in the control. Furthermore, C16:0 content in the milk fat was reduced to a greater extent than the increase in ALA content, as a 1.68 and 3.09 percentage unit increase occurred in ALA compared with a 3.6 and 5.25 percentage unit decrease in C16:0 for LFO and HFO, respectively, such that a negative correlation existed between ALA and C16:0 (r=-0.72). In conclusion, abomasal infusion of flaxseed oil dramatically increased the ALA content in plasma and milk fat. Because the replacement of C16:0 with ALA and C18:2n-6 occurred without changes in other FA presumed to be synthesized de novo in the mammary gland, this suggests that the preformed C16:0 was replaced, rather than being caused, by an overall suppression of de novo FA synthesis in the mammary gland.

Consumo materno de dois compostos bioativos da semente da linhaça sobre parâmetros bioquímicos e hormonais das mães e proles durante a lactação / Maternal consumption of two bioactive compounds from flax seed on biochemical and hormonal parameters of mothers and offspring during lactation

Avaliamos o efeito do consumo materno de SDG (Diglicosídeo Secoisolariciresinol) e de óleo de Linhaça+SDG sobre parâmetros bioquímicos e hormonais das ratas e das proles machos e fêmeas na lactação. As ratas lactantes foram separadas em: controle (C), ração controle cuja proteína foi caseína; (SDG): ração C com 400mg de SDG/Kg de ração; OLSDG: ração C com 400mg de SDG/Kg de ração e 7% de óleo de linhaça. No 14º e 20º dias de lactação as ratas foram ordenadas e no 21º dia foram sacrificadas por punção cardíaca. Leite e soro foram coletados para avaliação bioquímica e hormonal. Hormônios foram quantificados por radioimunoensaio. As proles machos e fêmeas foram sacrificadas aos 14 e 21 dias de idade. Os animais foram eviscerados para análise da composição corporal. Monitoramos a ingestão alimentar e a massa corporal (MC) durante o período experimental. As ratas SDG apresentaram maior gordura corporal (GC; +39%), enquanto as OLSDG menor conteúdo mineral (-20%) e trigliceridemia (TG) (-39%). As ratas SDG e OLSDG apresetaram hiperprolactinemia (+389% e 153%, respectivamente) sem alteração na concentração de estradiol. No 14º dia de lactação, o leite das ratas OLSDG apresentou menores teores de lactose (-17%) e de proteínas (-20%) e o das ratas SDG apenas menor teor de proteína (-21%). A partir do 13º dia de lactação tanto os machos quanto as fêmeas OLSDG apresentaram menor MC (-14%, -16%, respectivamente). No 14º dia de lactação os machos SDG e OLSDG apresentaram menor gordura corporal (-24%, -55%, respectivamente) e a prole SDG maior massa de gordura visceral (+39%). Os machos SDG apresentaram maiores concentrações de TG (+105%) e hipoprolactinemia (-41%). Os machos OLSDG também apresentaram hipoprolactinemia (-41%). As fêmeas SDG e OLSDG apresentaram maior estradiol aos 14 dias (+86% e +176%) que se normalizou aos 21 dias, maior colesterolemia (+16%) e as SDG apresentaram maior trigliceridemia (+74%). Aos 21 dias os machos e as fêmeas SDG e OLSDG...

We evaluated the mother's intake of SDG (Diglicoside secoisolariciresinol) and flaxseed oil + SDG upon biochemical and hormonal parameters of lactating female rats and the male and female offspring during lactation. The female lactating rats were divided into: Control (C): feeding a diet with casein; (SDG): feeding diet C added 400mg of SDG/Kg diet; (OLSDG): diet C added 400mg of SDG/Kg diet and 7% of flaxseed oil. Milk samples were obtained on the 14th and 20th days of lactation and the mothers were sacrificed and blood collected by cardiac puncture on the 21st day. Milk and serum were collected for biochemical and hormonal analysis. The male and female offsprings were sacrified on the 14th and 21th day. The hormonal dosages were measured by radioimunassay. The animals were completely eviscerated to analyze body composition. Body mass (BM) and food intake were monitored during all experimental period. The SDG rats showed higher fat mass (+39%) while the OLSDG rats showed lower mineral content (-20%) and triglycerides (TG) serum levels (-39%). The SDG and OLSDG rats showed higher prolactin levels (+339% and +153% respectively) without changes in serum estradiol. On the 14th day of lactation we observed lower lactose (-17%) and protein (-20%) content in the OLSDG rat's milk while in the SDG only lower protein (-21%). From the 13th day of lactation both the males and females OLSDG showed lower BM (-14%, -16%, respectively). On the 14th day the male SDG and OLSDG showed lower fat mass (-24%, -55%, respectively), and the SDG offspring showed higher visceral fat mass (+39%). The SDG male also showed higher TG levels (+105%) and lower prolactin levels (-41%). The OLSDG males also showed lower prolactin serum levels (-41%). The OLSDG female showed higher serum estradiol at 14 days (+86% e +176%), which normalized at 21 days and higher cholesterolemia (+16%) and the SDG female presented higher TG levels (+74%). On day 21th day the male and female SDG and OLSDG...

The effect of secoisolariciresinol diglucoside and flaxseed oil, alone and in combination, on MCF-7 tumor growth and signaling pathways.

Flaxseed (FS), an oilseed containing high amounts of the phytoestrogen lignan, secoisolariciresinol diglucoside (SDG), and n-3 fatty acid, alpha-linolenic acid-rich oil (FO), has been shown to inhibit the growth of established human breast tumors (MCF-7) in ovariectomized (OVX) athymic mice. However, the major FS component responsible for this effect and the mechanism(s) of its action are unclear. Hence, this study determined, in a 2 x 2 factorial design, the effect of SDG and FO, alone or in combination, on the growth of established human estrogen receptor positive (ER+) breast tumors and the potential mechanism(s) of its action. OVX mice with established ER+ human breast tumors (MCF-7) were treated for 8 wk with basal diet (BD, control) or BD supplemented with SDG (1 g/kg), FO (38.5 g/kg), or SDG + FO. All treatments reduced the tumor growth, but SDG had the greatest effect primarily through reducing tumor cell proliferation rather than increasing apoptosis. SDG had a main effect in the reduction of PS2, BCL2, and IGF-1R mRNA expression, whereas FO had a main effect only in PAKT reduction. SDG alone also lowered the ERalpha, ERbeta, EGFR, BCL2 mRNA, and PMAPK protein, indicating that its effect involves the modulation of the ER- and growth factor receptor-mediated signaling pathways.